GENEVA, July 2 -- THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE filed a patent application (US2025/060021) for “THIOMORPHOLINO (TMO)-BASED THERAPEUTICS FOR THE TREATMENT OF PSORIASIS AND OTHER INFLAMMATORY SKIN DISEASES”. With publication no. WO/2026/136485, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/7125
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....